Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma

Abstract

MMRD pancreatic cancers have distinct clinical, pathological and genomic profiles. Patients with MMRD pancreatic cancer should be considered for basket trials targeting enhanced immunogenicity or the unique genomic drivers in these malignancies.